Howard V. Owens Jr.

Array ( [id] => 534153 [patent_doc_number] => RE039464 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2007-01-09 [patent_title] => 'Oligonucleolotides having site specific chiral phosphorothioate internucleoside linkages' [patent_app_type] => reissue [patent_app_number] => 10/925348 [patent_app_country] => US [patent_app_date] => 2004-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 23488 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039464.pdf [firstpage_image] =>[orig_patent_app_number] => 10925348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468163 [patent_doc_number] => 20040167092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Medicaments' [patent_app_type] => new [patent_app_number] => 10/469792 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5447 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20040167092.pdf [firstpage_image] =>[orig_patent_app_number] => 10469792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7475129 [patent_doc_number] => 20040122223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Non-natural nucleotides and dinucleotides' [patent_app_type] => new [patent_app_number] => 10/467418 [patent_app_country] => US [patent_app_date] => 2004-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28002 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122223.pdf [firstpage_image] =>[orig_patent_app_number] => 10467418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 695291 [patent_doc_number] => 07071176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-04 [patent_title] => 'Aryl phosphate derivatives of AZT having anti-HIV activity' [patent_app_type] => utility [patent_app_number] => 10/726073 [patent_app_country] => US [patent_app_date] => 2003-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 9625 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/071/07071176.pdf [firstpage_image] =>[orig_patent_app_number] => 10726073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314279 [patent_doc_number] => 20040033981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis' [patent_app_type] => new [patent_app_number] => 10/601863 [patent_app_country] => US [patent_app_date] => 2003-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15456 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0033/20040033981.pdf [firstpage_image] =>[orig_patent_app_number] => 10601863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 543082 [patent_doc_number] => 07169766 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-30 [patent_title] => 'Methods and compositions for treating hepatitis C virus' [patent_app_type] => utility [patent_app_number] => 10/602976 [patent_app_country] => US [patent_app_date] => 2003-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 49513 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/169/07169766.pdf [firstpage_image] =>[orig_patent_app_number] => 10602976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639196 [patent_doc_number] => 20030212015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Specific modulation of Th1/Th2 cytokine expression by ribavirin in activated T-lymphocytes' [patent_app_type] => new [patent_app_number] => 10/460897 [patent_app_country] => US [patent_app_date] => 2003-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5493 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212015.pdf [firstpage_image] =>[orig_patent_app_number] => 10460897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6679079 [patent_doc_number] => 20030229220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Oligomer phosphoramidite compositions and processes for synthesizing the same' [patent_app_type] => new [patent_app_number] => 10/444445 [patent_app_country] => US [patent_app_date] => 2003-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14388 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229220.pdf [firstpage_image] =>[orig_patent_app_number] => 10444445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664750 [patent_doc_number] => 20030204077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'RNA isolation reagent and methods' [patent_app_type] => new [patent_app_number] => 10/442946 [patent_app_country] => US [patent_app_date] => 2003-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3149 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20030204077.pdf [firstpage_image] =>[orig_patent_app_number] => 10442946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 738081 [patent_doc_number] => 07034147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Nucleoside analog libraries' [patent_app_type] => utility [patent_app_number] => 10/379607 [patent_app_country] => US [patent_app_date] => 2003-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 16405 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/034/07034147.pdf [firstpage_image] =>[orig_patent_app_number] => 10379607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6679078 [patent_doc_number] => 20030229219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Preparation of phosphorothioate oligomers' [patent_app_type] => new [patent_app_number] => 10/423440 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21154 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229219.pdf [firstpage_image] =>[orig_patent_app_number] => 10423440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6679078 [patent_doc_number] => 20030229219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-11 [patent_title] => 'Preparation of phosphorothioate oligomers' [patent_app_type] => new [patent_app_number] => 10/423440 [patent_app_country] => US [patent_app_date] => 2003-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21154 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20030229219.pdf [firstpage_image] =>[orig_patent_app_number] => 10423440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825775 [patent_doc_number] => 20030236397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Process for preparing beta-L-2\'deoxy-thymidine' [patent_app_type] => new [patent_app_number] => 10/413020 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3801 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236397.pdf [firstpage_image] =>[orig_patent_app_number] => 10413020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6664754 [patent_doc_number] => 20030204081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-30 [patent_title] => 'Reduced malto-oligosaccharides' [patent_app_type] => new [patent_app_number] => 10/378228 [patent_app_country] => US [patent_app_date] => 2003-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5530 [patent_no_of_claims] => 108 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20030204081.pdf [firstpage_image] =>[orig_patent_app_number] => 10378228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701158 [patent_doc_number] => 20030224038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Cross-linkable phosphonate-containing supramolecular complexes and their use for delivery of therapeutic and diagnostic agents' [patent_app_type] => new [patent_app_number] => 10/370221 [patent_app_country] => US [patent_app_date] => 2003-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7131 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224038.pdf [firstpage_image] =>[orig_patent_app_number] => 10370221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7241187 [patent_doc_number] => 20040158055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Protection of nucleosides' [patent_app_type] => new [patent_app_number] => 10/365183 [patent_app_country] => US [patent_app_date] => 2003-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21167 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20040158055.pdf [firstpage_image] =>[orig_patent_app_number] => 10365183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1014815 [patent_doc_number] => 06894159 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-17 [patent_title] => 'Process for the preparation of 2′-fluoro-5-methyl-beta-L-arabino-furanosyluridine' [patent_app_type] => utility [patent_app_number] => 10/351222 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4539 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/894/06894159.pdf [firstpage_image] =>[orig_patent_app_number] => 10351222 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6730738 [patent_doc_number] => 20030186928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Method for reducing intraocular pressure' [patent_app_type] => new [patent_app_number] => 10/347255 [patent_app_country] => US [patent_app_date] => 2003-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7763 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20030186928.pdf [firstpage_image] =>[orig_patent_app_number] => 10347255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674690 [patent_doc_number] => 20040127428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Use of D-ribose, including as a topical vehicle, to promote faster healing, including from surgical procedures' [patent_app_type] => new [patent_app_number] => 10/330566 [patent_app_country] => US [patent_app_date] => 2002-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6842 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127428.pdf [firstpage_image] =>[orig_patent_app_number] => 10330566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7438329 [patent_doc_number] => 20040002596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Nucleoside compounds and uses thereof' [patent_app_type] => new [patent_app_number] => 10/318476 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10897 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002596.pdf [firstpage_image] =>[orig_patent_app_number] => 10318476 [rel_patent_id] =>[rel_patent_doc_number] =>)